Growing community of inventors

Calgary, Canada

Donna Lorraine Senger

Average Co-Inventor Count = 4.58

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 63

Donna Lorraine SengerStephen Mark Robbins (7 patents)Donna Lorraine SengerJennifer Joy Rahn (7 patents)Donna Lorraine SengerPaul Kubes (5 patents)Donna Lorraine SengerDaniel Abraham Muruve (3 patents)Donna Lorraine SengerArthur Wing Sze Lau (3 patents)Donna Lorraine SengerSaurav Roy Choudhury (3 patents)Donna Lorraine SengerLiane Babes (3 patents)Donna Lorraine SengerJustin MacDonald (1 patent)Donna Lorraine SengerJennifer Rahn (1 patent)Donna Lorraine SengerDonna Lorraine Senger (7 patents)Stephen Mark RobbinsStephen Mark Robbins (8 patents)Jennifer Joy RahnJennifer Joy Rahn (7 patents)Paul KubesPaul Kubes (6 patents)Daniel Abraham MuruveDaniel Abraham Muruve (5 patents)Arthur Wing Sze LauArthur Wing Sze Lau (3 patents)Saurav Roy ChoudhurySaurav Roy Choudhury (3 patents)Liane BabesLiane Babes (3 patents)Justin MacDonaldJustin MacDonald (1 patent)Jennifer RahnJennifer Rahn (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Arch Cancer Therapeutics, Inc. (4 from 4 patents)

2. Arch Biopartners, Inc. (3 from 3 patents)


7 patents:

1. 11666631 - DPEP-1 binding compositions and methods of use

2. 11286278 - DPEP-1 binding agents and methods of use

3. 11083773 - Peptides that block leukocyte recruitment and methods of use

4. 10493127 - DPEP-1 binding compositions and methods of use

5. 9464114 - Peptides that block leukocyte recruitment and methods of use

6. 9095541 - Brain tumor targeting peptides and methods

7. 8530429 - Brain tumor targeting peptides and methods

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/5/2026
Loading…